FERTIN PHARMA A/S: Financial statements 2016
CVR: 25834844
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 855,745,000 and a net result of DKK 100,073,000 compared with DKK 63,953,000 the year before. That is an increase of 6.9% compared with the year before. The profit margin was 11.7%. Equity in the 2016 report amounted to DKK 659,605,000. The solvency ratio was 43.5%. The company had 530 employees in the financial year.
- Revenue
- DKK 855,745,000
- Gross Profit
- DKK 546,474,000
- Profit/Loss
- DKK 100,073,000
- Equity
- DKK 659,605,000
- Total Assets
- DKK 1,517,001,000
- Employees
- 530
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 855.7M | 546.5M | 100.1M | 659.6M | 530 |
| 2015 | 800.7M | 467.8M | 64M | 560.9M | 543 |
| 2014 | 694.1M | 419.5M | 42.2M | 495M | 446 |
Official annual report
Find more companies like FERTIN PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
FERTIN PHARMA A/S has published its annual report for 2015. Revenue came to DKK 800,654,000, and the net result was DKK 63,953,000.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.